UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - EIDOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,849,620,000
+291.2%
14,057
+50.2%
0.00%
Q3 2020$472,809,000
+136.2%
9,357
+122.8%
0.00%
Q2 2020$200,214,000
+8597.4%
4,200
+6462.5%
0.00%
Q3 2019$2,302,000
+15.7%
640.0%0.00%
Q2 2019$1,989,000640.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$55,047,00023.98%
Opaleye Management Inc. 315,550$15,459,0004.10%
RA Capital Management 2,162,671$105,949,0003.35%
Board of Trustees of The Leland Stanford Junior University 265,670$13,015,0002.63%
Cormorant Asset Management, LP 1,100,000$53,889,0002.50%
Parkman Healthcare Partners LLC 81,085$3,972,0001.84%
EAM Global Investors LLC 38,535$1,888,0001.10%
Redmile Group, LLC 689,478$33,778,0000.95%
Perceptive Advisors 686,922$33,652,0000.88%
EAM Investors, LLC 55,532$2,721,0000.84%
View complete list of EIDOS THERAPEUTICS INC shareholders